Skip to main content
Joseph Cleveland, MD, Oncology, San Luis Obispo, CA

JosephClevelandMD

Oncology San Luis Obispo, CA

Medical Oncologist and Hematologist at The University of California, Los Angeles

Dr. Cleveland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cleveland's full profile

Already have an account?

  • Office

    892 Aerovista Pl
    Suite 240
    San Luis Obispo, CA 93401
    Phone+1 805-541-8252

Summary

  • Dr. Cleveland is a medical oncologist and hematologist who practices in San Luis Obispo, California with UCLA Health. He treats patients with all types of cancer and hematologic conditions and is board certified in both medical oncology and hematology. A diagnosis of cancer is a truly vulnerable and uncertain moment in life, and he is a firm believer in placing compassion, humanism, and each patient’s quality of life at the forefront of care.

    Dr. Cleveland obtained his medical degree from the Texas A&M University College of Medicine, where he was inducted into both the Alpha Omega Alpha Honor Society and Gold Humanism Honor Society. He completed Internal Medicine Residency at The University of California, San Francisco, where he was elected for the residency humanism in medicine award. He completed Fellowship training in Medical Oncology & Hematology at Stanford University where he served as a chief fellow and was recognized for the fellowship humanitarianism award. He received his Bachelor of Science degree with honors in Geological Sciences from the University of Texas at Austin.

    Prior to joining UCLA Health, Dr. Cleveland conducted both basic and translational research in B and T cell lymphomas at UCSF and Stanford University and presented in international and national conferences.

    Dr. Cleveland is a member of the American Society of Clinical Oncology, American Society of Hematology, Alpha Omega Alpha Honor Society, and Gold Humanism Honor Society.

Education & Training

  • Stanford Health Care
    Stanford Health CareFellowship, Hematology and Medical Oncology, 2021 - 2024
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2018 - 2021
  • Texas A&M; Health Science Center College of Medicine
    Texas A&M; Health Science Center College of MedicineClass of 2018
  • The University of Texas at Austin
    The University of Texas at AustinB.S., Geological Sciences, 2010 - 2014

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2021 - 2028
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha Honor Society Texas A&M Health Science Center College of Medicine, 2018
  • Gold Humanism Honor Society The Arnold P. Gold Foundation, 2018

Publications & Presentations

PubMed

Journal Articles

  • Primary CNS lymphoma: update on molecular pathogenesis and therapy  
    Shirley Mo, Joseph Cleveland, James L Rubenstein, Leukemia & Lymphoma, 10/26/2022
  • Survival and Patient-Reported Outcomes of Older Adults with Primary Central Nervous System Lymphoma on Low-Dose Lenalidomide  
    Mazie Tsang, MD, Joseph Cleveland, MD, Miguel Cerejo, DO, Humin Geng, PhD, and James Rubenstein MD, PhD, Blood, 11/5/2020
  • Tumor Metabolism and Neurocognition in CNS Lymphoma  
    Joseph Cleveland, MD, Geng H, Tsang M, Subbaraj L, Chen L, Lu M, Sharma J, Vigneron DB, Kurhanewicz J, LaFontaine M, Luks T, Barshop BA, Gangoiti J, Villanueva-Meyer J..., Neuro-Oncology, 2/24/2021
  • Join now to see all

Abstracts/Posters

  • Outcomes of autologous transplant, allogeneic transplant, and CAR T cell therapy in TP53 altered mantle cell lymphoma: a multi-institution retrospective analysis
    M. Messmer, A. Stack, M. Deng, E. Handorf, N. Kapoor, Y. Sawalha, A. M. Bock, Y. Wang, K. Graf, B. Greenwell, J. Cleveland, R. Advani, D. Adrianzen Herrera, E. Cai, M...., Hematological Oncology, 6/9/2023
  • Regulation of CNS Lymphoma Progression by the Myeloid Microenvironment
    Hua-Xin Gao, Eleanor Fraser, Mario Merlini, Huimin Geng, Lingjing Chen, Ming Lu, Yasmin Mosfegh, Joseph Cleveland, Jae Kyu Ryu, Jigyasa Sharma, Kwun Wah Wen, David Sol..., 63rd ASH Annual Meeting and Exposition, Atlanta, Georgia, 11/5/2021
  • Older Patients with Primary Central Nervous System Lymphoma (PCNSL) in the Modern Era: Real World (RW) Outcomes of Post-Induction Therapy
    Kevin A. David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, Nishitha Reddy, Dougl..., Lugano Conference, 5/25/2021
  • Join now to see all

Professional Memberships